Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.

ABSTRACT:

Objective

This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan.

Methods

People aged 18-35 years with a confirmed diagnosis of schizophrenia within the past 5 years were surveyed in the UK, Germany, and Italy. Treatment goals were assessed via a validated best-worst scaling instrument, where participants evaluated subsets of 13 possible treatment goals identified using a balanced incomplete block design. Participants identified the most and least important goals within each task. Data were also collected on current treatment and preference for daily oral versus long-acting injectable (LAI) treatment. Hierarchical Bayes was used to identify preference weights for the goals, and latent class

SUBMITTER: Bridges JF 

PROVIDER: S-EPMC5757991 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature